# Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Final Monograph for Combination Drug Products; Correction
> **Food and Drug Administration** · Final rule; correction. · Published 2003-04-14 · Effective 2004-12-23 · 68 FR 17881
## Document
- **Document number:** 03-9067
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 68 FR 17881
- **CFR reference:** 21 CFR 341
- **Publication date:** 2003-04-14
- **Effective date:** 2004-12-23
- **HHS docket:** Docket No. 76N-052G
## Abstract

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of December 23, 2002 (67 FR 78158). The document issued a final monograph that established conditions under which over-the-counter (OTC) cold, cough, allergy, bronchodilator, and antiasthmatic (cough-cold) combination drug products are generally recognized as safe and effective and not misbranded as part of its ongoing review of OTC drug products.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2003/04/14/03-9067/cold-cough-allergy-bronchodilator-and-antiasthmatic-drug-products-for-over-the-counter-human-use)
---
*AI Analytics · CC0 1.0*